UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

Continued strong performance in the third quarter of 2023 – Biotech Investments

EQS-News: SYNLAB AG / Key word(s): Quarter Results Continued strong performance in the third quarter of 2023 08.11.2023 / 07:30 CET/CEST The issuer is solely

November 9, 2023

Financial incentives prove successful in supporting pregnant smokers to quit

Rewards and financial incentives are successful methods to help people quit smoking, according to a new Cochrane review co-led by a University of Massachusetts Amherst

January 13, 2025

Prenatal Mediterranean diet reduces offspring obesity

The relationship between maternal MedDiet adherence during gestation and overweight offspring risk.

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.